TMCI Treace Medical Concepts Inc
Price (delayed)
$8.32
Market cap
$520.99M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.9
Enterprise value
$578.88M
Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The
Highlights
TMCI's revenue is up by 12% YoY and by 3.2% QoQ
Treace Medical Concepts's gross profit has increased by 11% YoY and by 2.9% from the previous quarter
Treace Medical Concepts's quick ratio has increased by 19% QoQ but it has decreased by 7% YoY
The equity has declined by 18% year-on-year but it has increased by 8% since the previous quarter
Key stats
What are the main financial stats of TMCI
Market
Valuations
Earnings
Shares outstanding
62.62M
Market cap
$520.99M
Enterprise value
$578.88M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.59
Price to sales (P/S)
2.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.77
Revenue
$209.36M
Gross profit
$168.26M
Operating income
-$55.69M
Net income
-$55.74M
EBIT
-$50.49M
EBITDA
-$39.72M
Free cash flow
-$48.76M
Per share
Balance sheet
Liquidity
EPS
-$0.9
EPS diluted
-$0.9
Free cash flow per share
-$0.79
Book value per share
$1.81
Revenue per share
$3.37
TBVPS
$3.16
Total assets
$217.09M
Total liabilities
$104.2M
Debt
$69.24M
Equity
$112.89M
Working capital
$126.48M
Debt to equity
0.61
Current ratio
4.62
Quick ratio
3.34
Net debt/EBITDA
-1.46
Margins
Efficiency
Dividend
EBITDA margin
-19%
Gross margin
80.4%
Net margin
-26.6%
Operating margin
-26.6%
Return on assets
-24.8%
Return on equity
-48.9%
Return on invested capital
-23.1%
Return on capital employed
-27.7%
Return on sales
-24.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TMCI stock price
How has the Treace Medical Concepts stock price performed over time
Intraday
2.09%
1 week
-3.03%
1 month
-6.94%
1 year
-30.67%
YTD
11.83%
QTD
-0.83%
Financial performance
How have Treace Medical Concepts's revenue and profit performed over time
Revenue
$209.36M
Gross profit
$168.26M
Operating income
-$55.69M
Net income
-$55.74M
Gross margin
80.4%
Net margin
-26.6%
The operating margin is up by 13% QoQ and by 3.3% YoY
The company's net income fell by 13% YoY but it rose by 9% QoQ
TMCI's net margin is up by 12% QoQ
TMCI's revenue is up by 12% YoY and by 3.2% QoQ
Growth
What is Treace Medical Concepts's growth rate over time
Valuation
What is Treace Medical Concepts stock price valuation
P/E
N/A
P/B
4.59
P/S
2.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.77
The EPS has declined by 11% year-on-year but it is up by 9% since the previous quarter
The equity has declined by 18% year-on-year but it has increased by 8% since the previous quarter
TMCI's P/B is 2.3% above its last 4 quarters average of 4.4
TMCI's revenue is up by 12% YoY and by 3.2% QoQ
The P/S is 3.2% below the last 4 quarters average of 2.5
Efficiency
How efficient is Treace Medical Concepts business performance
The return on equity has declined by 44% year-on-year but it has increased by 4.3% since the previous quarter
Treace Medical Concepts's return on invested capital has decreased by 31% YoY but it has increased by 8% QoQ
Treace Medical Concepts's ROA has decreased by 24% YoY but it has increased by 6% from the previous quarter
The return on sales is up by 13% since the previous quarter
Dividends
What is TMCI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TMCI.
Financial health
How did Treace Medical Concepts financials performed over time
TMCI's total assets is 108% greater than its total liabilities
Treace Medical Concepts's quick ratio has increased by 19% QoQ but it has decreased by 7% YoY
TMCI's total assets is down by 14% year-on-year
TMCI's debt is 39% lower than its equity
The debt to equity has grown by 22% YoY but it has contracted by 8% from the previous quarter
The equity has declined by 18% year-on-year but it has increased by 8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.